Healthcare consolidation must be accompanied with integration of care in order to be successful, explained Robert Nesse, MD, the senior director of Policy and Payment Reform at Mayo Clinic.
Healthcare consolidation must be accompanied with integration of care in order to be successful, explained Robert Nesse, MD, the senior director of Policy and Payment Reform at Mayo Clinic. If consolidation is not accomplished correctly it may raise prices without improving quality, or it may become a great source of confusion for both patients and providers.
Transcript (modified)
How can healthcare consolidation be done right to ensure lower costs and better quality of care?
Healthcare consolidation is one model, but healthcare consolidation without integration of the care model is not going to work. What we’re seeing, and what we’ve seen in the past, is groups buying other groups. So hospitals are saying “We must get bigger” or provider groups are saying “Let’s get bigger” without any real thought to what they hope to accomplish besides getting bigger.
So integration of care, in my mind, is the key to all of this and it has to provide seamless handoffs for patients in hospitals, for outpatient services, and it needs to provide a base within the community for the patient as well as within a hospital setting. Then we will make progress in healthcare.
What are the negative outcomes that happen when consolidation in healthcare is not done right?
When consolidation is not done appropriately, I think you end up without the balance needed for success. So, for example, if consolidation is done because you simply want to capture market share, well that could actually raise prices without any discernible difference in the quality of care offered to patients: it’s not balanced against the need for coordinated care or aligned purpose for the providers.
I also believe that consolidation not done right leads to chaos. Because you have a group of providers, or a group of insurers, or some other consolidated group, and if the information systems aren’t there or the analytics aren’t aligned, it can actually be quite confusing for both patients and providers in the system.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More